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Abstract 
 
Aim: Many studies have provided evidence of cognitive deficits in individuals in an “At 
Risk Mental State” (ARMS) for psychosis, which makes neuropsychology potentially 
useful in the early detection of psychosis. As depression is an important differential 
diagnosis in prodromal states of psychosis, the specificity of neurocognitive deficits in 
ARMS individuals as compared to non-psychotic depressive disorders is investigated.  
Method: Neurocognitive performance of four groups was analysed: 22 ARMS 
individuals with later transition to psychosis (ARMS-T), 25 ARMS individuals without 
later transition to psychosis (ARMS-NT), 34 controls with depressive disorders and 76 
healthy controls. The subjects were assessed with a neurocognitive test battery covering 
the domains intelligence, executive function and attention/working memory. 
MANOVAs, ANOVAs and Tukey’s tests were applied after adjustment for 
confounding factors. 
Results: ARMS-T showed significant cognitive deficits in working memory and in 
certain executive function tasks compared to healthy controls as well as to controls with 
depression. Controls with depression were only impaired in time per move in the tower 
of Hanoi test when compared to healthy controls. ARMS-NT performed similar to 
ARMS-T, but additionally showed deficits in attention. 
Conclusions:  
The psychosis prodrome seems to be associated with cognitive deficits in the domains 
of working memory and executive function. In contrast, depressive patients showed no 
cognitive deficits but slowing in one executive function task. Neurocognitive testing 
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might therefore contribute to the differential diagnosis between prodromal psychosis 
and depressive disorders. 
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Introduction 
The diagnostic criteria for psychotic disorders are currently revised with the aim to base 
future classification systems on more objective signs and to incorporate individuals in 
an “At Risk Mental State” for psychosis (ARMS).1 Possible approaches to detect 
ARMS individuals and to identify risk factors for the transition to psychosis are 
suggested by genetic, neuroimaging, neurophysiological and/or neuropsychological 
studies.1-6 Among these methods, neurocognitive evaluation might be a useful approach, 
since many studies have provided evidence of neurocognitive deficits not only in 
chronic schizophrenia 7,8 and first episode psychosis 9,10 but and also in the prodromal 
phase of the disease.11-18 
However, the specificity of the cognitive deficits in prodromal psychosis as compared to 
depression has – to our knowledge- not yet been investigated. This is surprising, as the 
question of differential diagnosis of depressive disorders and prodromal psychosis is of 
great clinical interest. Depression is one of the first and most frequent initial signs in the 
prodromal phase of schizophrenic psychosis 19-23 and classification into either ARMS 
state or depressive disorder is often difficult.  
Other studies comparing the neurocognitive performance of ARMS individuals with 
non-psychotic psychiatric control groups showed heterogeneous results. Ilonen et al.24 
found no significant difference between the groups, while Lindgren et al.25 found, that 
ARMS performed worse on visuospatial tasks than the psychiatric control group. 
According to studies on cognitive deficits in frank psychosis versus affective disorders, 
cognitive impairment in non-psychotic depression is less severe than in psychotic 
depression 26-28 or schizophrenia 26,28-30. Cognitive deficits in patients with psychosis 
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seem to be characterized by a distinct pattern of cognitive deficits which involves 
impairment in verbal memory, working memory, attention and executive functions 
26,29,31-33
, while cognitive deficits in depression follow a more variable pattern and 
studies show heterogeneous results most likely due to factors like different clinical 
subtypes, severity, age and medication.34 Cognitive deficits in depression are more 
related to clinical symptoms, while cognitive deficits in psychosis are a more stable 
aspect of the disease and not related to psychotic symptoms.35 The neuropsychological 
profile of major depression and psychosis may overlap, as deficits in psychomotor 
speed 34,36,37, processing speed 38, attention 36,37, memory 36,37,39 and executive function 
34,36-40
 were – even if not consistently- also reported in patients with major depression.   
As there seem to be differences especially concerning the severity of cognitive deficits 
in frank psychosis versus major depression, the aim of the present study is to investigate 
if a neurocognitive evaluation may also help in the differential diagnosis of prodromal 
psychosis and depressive disorders.  
We assessed neurocognitive baseline data of ARMS individuals, controls with 
depression (DC) and healthy controls (HC), using intelligence, executive functioning, 
attention and working memory tasks. ARMS individuals were further divided into two 
subgroups: ARMS-T who made a transition to manifest psychosis during follow-up and 
ARMS-NT without later transition. 
According to the studies comparing patients with major depression and psychosis 
explained above, we expected ARMS-T to differentiate from DC in severity of the 
cognitive deficits and also in the pattern of the neuropsychological profile. As our DC 
group mainly consisted of individuals with a moderate depressive episode, we did not 
expect a severe cognitive impairment in this group. From previous studies in our 
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research project 14,41 and other groups (for review see 5,42) we expected working 
memory, processing speed and executive function to be specifically impaired in ARMS-
T patients.  
 
Methods 
Study design 
The neurocognitive data analysed in this paper were collected within the FePsy 
(Früherkennung von Psychosen; early detection of psychosis) study at the University 
Psychiatric Outpatient Department, Basel, Switzerland. It is an open, prospective 
clinical study of all consecutive referrals to our specialized clinic for the early detection 
of psychosis. The overall study and preliminary results have been described by Riecher-
Rössler et al.2,14  
 
Subjects 
The sample of the present study consisted of 76 healthy controls (HC), 25 ARMS-NT, 
22 ARMS-T and 34 DC. ARMS was assessed using the Basel Screening Instrument for 
Psychosis (BSIP), which is based on the DSM-III-R prodromal symptoms as well as 
other prodromes as derived from literature and four items of the Brief Psychiatric 
Rating Scale (BPRS43). All ARMS individuals included underwent an entry 
examination, which included BPRS, Scale for the Assessment of Negative Symptoms 
(SANS44) and the neurocognitive test battery. They were followed up at regular 
intervals for at least two years in order to evaluate transition to psychosis. The follow-
up duration in the present study ranged from 2.3 to 11.1 years, with a mean of 9.3 years. 
Criteria for ARMS status and transition to psychosis in the follow-up can be seen in 
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Table 1 and are described in more detail by Riecher-Rössler et al.14,45 The 
neurocognitive data analyzed in this paper were obtained at study entry. 
 
--- Insert Table 1 about here --- 
 
Exclusion criteria for ARMS individuals were: previous episode of schizophrenic 
psychosis (treated with major tranquillizers for more than 3 weeks), psychosis clearly 
due to organic reasons or substance abuse, or psychotic symptoms within a clearly 
diagnosed depression or borderline personality disorder. ARMS-NT were included if 
they had a follow-up period of at least two years.  
DC were patients of the University Psychiatric Outpatient Department of Basel and 
were included if they fulfilled the criteria of a non-psychotic depressive disorder 
according to ICD-10.  
HC were recruited from a commercial school, hospital staff, and through advertisements 
and were not included if they had a current or former psychiatric disorder or 
neurological disease, serious medical condition, substance abuse, or a family history of 
psychiatric disorder.  
Exclusion criteria for all participants were: age younger than 18 years, insufficient 
knowledge of German or IQ <70 or substance abuse other than cannabis. After 
complete description of the study to the subjects, written informed consent was obtained 
from all participants. The study was approved by the Ethics Committee of Basel, 
Switzerland (EKBB). 
 
Measures  
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The neurocognitive test battery used is mainly based on computer-tests and paper-pencil 
tests conducted by psychologists or trained students of psychology. To counteract the 
modulation of reaction time or performance due to strategic emphasis of either reaction 
time or performance (speed-accuracy trade-off), compound measures were applied in 
some variables, i.e. an average standard score (Z-Score) of both the error measures and 
the reaction times.46 Neurocognitive tests were assigned to the neuropsychological 
domains general intelligence, attention/working memory and executive functions 
according to Riecher-Rössler et al.:14 
- Intelligence: the “Mehrfachwortschatztest” (MWT-A47) assesses verbal abilities 
while the “Leistungsprüfsystem” (LPS-348) assesses abstract thinking abilities. A 
verbal and a nonverbal IQ variable were derived from the tests.  
- Executive function: Tower of Hanoi (ToH49) is a test that demands planning and 
goal-oriented behavior. This computerized test comprises a four- and a five-disc 
task. Outcome parameters were the number of moves (taking speed-accuracy trade-
off into account) and time per move.   
The Wisconsin Card Sorting Test (WCST50) demands flexible shifts between three 
cognitive sets in order to avoid perseveration errors. Outcome parameters were 
number of perseveration errors and proportion of perseveration errors compared to 
overall errors (perseveration score).  
The Go/No-Go test (TAP, Testbatterie zur Aufmerksamkeitsprüfung51) demands the 
selective response to two out of five visually similar stimuli. Omissions and false 
alarms (both adjusted for speed-accuracy trade-off) were used as outcome 
parameters. 
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- Working memory and attention: The TAP working memory test forces the subject to 
match visually presented stimuli in terms of a 2-back task. This test demands the 
ability of a continuous control about the information flow in the short-term memory. 
Omissions and false alarms (both adjusted for speed-accuracy trade-off) were used 
as outcome parameters. 
The Continuous Performance task (CPT52) measures sustained visual attention. Four 
letters are consecutively shown in a randomized order. Whenever the letter O 
(prime) is followed by the letter X (target) the subject has to press the button as 
quickly as possible. False alarms and omissions (both adjusted for speed-accuracy 
trade-off) as well as slowing in the second half of the test compared to the first part 
were evaluated.   
 
Statistical procedures 
Statistical analyses were operated with the statistics program R (Version 2.9.053). In 
order to prepare the neurocognitive data for further processing, Box-Cox 54, logarithmic 
and inverse tangent transformations were performed to ensure normal distribution and 
homoscedasticity. Demographic characteristics (age, gender, and education) were 
compared between groups using Chi-square, Kruskal-Wallis and Monte Carlo tests. Use 
of cannabis and medication (benzodiazepines, neuroleptics, antidepressants) were 
compared between the groups of patients with Monte Carlo tests. Neurocognitive 
variables were tested for influence of substance use and demographic characteristics 
and, if necessary, adjusted for this influence.  
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Multivariate analyses of variance (MANOVAs) were carried out to address the question 
whether there are differences in the neuropsychological domains executive function, 
attention/working memory and intelligence between the groups.  
In case the MANOVA showed significant group differences in a neuropsychological 
domain, analysis of variance (ANOVA) were used to test overall group differences for 
single variables. Post-hoc analyses including 95% confidence intervals were calculated 
using Tukey’s honest significance test.  
 
Results  
Sample characteristics and confounding factors 
Table 2 summarizes the sample characteristics of all four groups. There were no 
significant differences between the groups regarding gender (p=.23) and age (p=.46). 
However, significant group differences were found concerning education (p<.01), use of 
neuroleptics (only chlorprothixene as a sedating low potency neuroleptic) (p=.06) and 
use of antidepressants (p=.02). As there could potentially be confounding of 
neurocognitive parameters by age, education or benzodiazepines we statistically 
adjusted for these influences.  
    ---Insert Table 2 about here--- 
Table 3 indicates the severity of depression in the groups as ICD-10 codes. Depression 
in the groups was diagnosed by SKID-I interviews.55 The most prevalent diagnosis in 
DC was moderate depressive episode (17/34). Further, 49% of the ARMS individuals 
were diagnosed with a depressive disorder as comorbidity.  
 
    ---Insert Table 3 about here----- 
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Neurocognitive assessment 
MANOVAs revealed significant differences between the four groups concerning the 
cognitive domains of executive function (ToH, Go/NoGo, WCST; Wilks-lambda=.63, 
p<.001) and attention/working memory (CPT, TAP Working Memory; Wilks 
lambda=.78, p<.01). No group differences were found in the domain of intelligence 
(MWT, LPS; Wilks lambda=.94, p=.20). 
ANOVAs showed significant (p<.05) overall group differences for all parameters of the 
domains executive functions and attention/working memory except for the variable 
‘CPT slowing’ (p=.44) (for details see Table 4 in the supplemental material). Results of 
post hoc analyses (Tukey’s tests) are graphically represented in Figure 1, which shows 
group differences from HC in z-scores. Table 5 shows z-scores, 95% confidence 
interval and p-value of Tukey`s tests. 
 
--- Insert Figure 1 and Table 5 about here --- 
 
ARMS-T showed significant deficits in working memory and in most executive 
function tests compared to HC, namely in the TAP Go/NoGo paradigm and in the 
accuracy measure (number of moves) of the Tower of Hanoi. 
DC were significantly slower in the Tower of Hanoi than HC but showed no deficits in 
accuracy in this task. No other statistically significant cognitive deficits were found in 
DC.  
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ARMS-NT as compared to HC showed a significantly increased number of 
perseveration errors (p<.01) and higher perseveration scores (p=.02) in the WCST as 
well as significant deficits in a parameter of working memory (omissions; p=.01) and in 
the attention task CPT (false alarm; p<.01). 
The direct comparison of ARMS-T and DC (Table 5) showed that ARMS-T have 
specific deficits in working memory (both parameters), accuracy of Tower of Hanoi 
(number of moves, 4 discs) and the Go/NoGo paradigm (omissions). 
The direct comparison of DC and ARMS-NT as well as the comparison between 
ARMS-T and ARMS-NT revealed no statistically significant differences (for details 
see Table 6 in the supplementary material). 
 
Discussion  
The main objective of the present study was to contribute to the differential diagnosis of 
the early prodromal states of psychosis versus depressive disorders. To this end, we 
tried to clarify the specificity of neurocognitive deficits in ARMS-T compared to DC. 
ARMS-T showed specific deficits in working memory and in certain executive function 
tasks when compared to HC and DC. 
 
Cognitive deficits in ARMS-T versus DC 
In our study, DC performed similar to HC – except from slowing in the Tower of Hanoi 
task. Therefore, both DC and ARMS-T showed impairment in the Tower of Hanoi test, 
but when analyzing it in more detail, the deficits apply to different areas of the task. DC 
advanced slowly in the task compared to HC, but the quality of the performance (i.e. 
number of disk moves to solve the problem) was comparable to HC. In contrast, 
Cognition in ARMS for Psychosis 
  
13 
ARMS-T were significantly impaired in the quality of the performance in the Tower of 
Hanoi but not in speed. The Tower of Hanoi test demands strategical thinking and 
planning skills and not a quick reaction time. Therefore, we interpreted the reduced 
speed in the Tower of Hanoi test observed in the DC group as slow course of action 
probably best explained by the influence of emotional processes on decision making 56 
and rumination 57,58 and as probably not related to predominant psychomotor slowing. 
This argument is also supported by the fact that DC were not impaired in reaction time 
tests such as the Go/NoGo and the CPT.  
Cognitive deficits are a well established feature of depressive disorders, although the 
findings are heterogeneous (for review see27,34,36,40). One reason for our DC group to 
show few cognitive deficits and to perform similar to HC in most tests may be that few 
patients were suffering from a severe episode of depression and cognitive deficits in 
depression are closely related to severity of the episode.59 Another reason could be that 
our DC group consisted of individuals with a non-psychotic depression. Studies show 
that patients suffering from affective disorders with psychotic symptoms show 
comparable 26,28,32 or similar but less pronounced 33 cognitive deficits when compared to 
patients with schizophrenia, while patients with affective disorders without psychotic 
symptoms- corresponding to the DC evaluated in the present study- showed less 
cognitive deficits 26-28.  
The ARMS-T in our study were significantly more impaired than DC in working 
memory and certain executive function tasks. To our knowledge there are so far no 
other studies specifically comparing cognitive deficits in prodromal psychosis versus 
major depression. Hence, our results are difficult to compare to other studies in the 
literature. 
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Ilonen et al. 24 investigated neurocognitive functioning in ARMS individuals versus a 
psychotic and non-psychotic patient group. In contrast to our results, they found that 
ARMS did not differ from the non-psychotic group with respect to cognitive deficits. 
However, this study is not totally comparable to the present study, as the non-psychotic 
control group included several diagnostic entities according to DSM IV Axis I such as 
mood disorder, anxiety disorder and disorders usually first diagnosed in infancy, 
childhood, or adolescence. Another study 25 compared the neurocognitive performance 
of ARMS individuals to a non-psychotic psychiatric control group. They found that the 
ARMS group performed worse on visuospatial tasks than the control group. 
Further, there are studies comparing cognitive deficits in patients with non-psychotic 
depression and schizophrenia showing that the patients with schizophrenia were more 
impaired than the controls with depression in psychomotor speed, attention, learning 28, 
working memory 29,30, executive function, visual and verbal memory 30.  
 
Conceptualization of cognitive deficits in ARMS-T  
Working memory such as formulated by Baddeley 60 might be an appropriate 
framework to consistently conceptualize cognitive deficits found in ARMS-T 11,41,61. 
The observed deficits in the TAP Go/NoGo test, which first requires the successful 
memorization of visual patterns and then the selective response to 2 out of 5 of these 
patterns, might be related to deficits in spatial working memory also observed in other 
studies on subjects at ultra-high risk for psychosis 62. Furthermore, planning deficits 
such as observed in the Tower of Hanoi have been related to working memory 63,64 and, 
thus, ARMS-T’s deficits observed in the Tower of Hanoi might also be attributable to 
working memory dysfunction.   
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Cognitive deficits in ARMS-T versus ARMS-NT 
The neurocognitive profile of ARMS-NT was similar to the profile of ARMS-T. This 
relative similarity might be due to a proportion of ARMS-NT who are bearing a true 
risk for developing psychosis but have not (yet) made the transition to psychosis. 
Alternatively, the described deficits in ARMS-NT might be related to the presence of 
attenuated psychotic symptoms and brief intermitted psychotic symptoms in these 
patients.  
The differentiation of ARMS-T versus ARMS-NT evaluated in the present study 
showed stronger deficits in the ARMS-T than ARMS-NT, although the direct 
comparison of both ARMS groups revealed no statistically significant differences. But 
as our group has shown in a previous study 14 neurocognitive assessment can also help 
to predict transition to psychosis when combined with other assessment domains such 
as psychopathology. In this study, reduced speed of information processing combined 
with psychopathology was shown to be the measure that best predicted transition to 
psychosis.  
In another study by our group, verbal episodic memory was found to be significantly 
impaired in ARMS-T individuals compared to HC but not significantly when compared 
to ARMS-NT (Zimmermann R et al., 2011, unpublished data). The domain of verbal 
memory was not assessed in the present study. 
Other studies comparing ARMS who converted to psychosis during follow-up with 
those who did not, found reduced 13 or enhanced 15 speed of information processing, 
impaired IQ 13, executive function 13,16,18 attention 15, verbal memory 11-13,16 working 
memory 13,18 (not significant62), visual memory 18 and spatial memory 11 in psychosis-
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converters. In one study, no significant differences were found between psychosis-
converters and non-converters in attention 65 and in a study by Wood et al. 66 a decline 
of visual memory and attention over time predicted transition to psychosis. Seidman et 
al 17 found that psychosis-converters performed worse than non-converters in global 
neuropsychological functioning, but no neurocognitive variable predicted transition to 
psychosis beyond clinical variables. Reviews concluded that reduced procession speed, 
impaired verbal memory 5,42 and working memory 5 are the most frequently found 
neurocognitive parameters to predict transition to psychosis.  
 
Limitations 
Limitations of our study are the small group samples and that ARMS individuals in this 
study had a minimum follow-up period of only two years. While it has been shown that 
most ARMS individuals make the transition to psychosis within 12 months 14,67,68 it 
might be possible that a small percentage of ARMS individuals develop psychosis after 
the follow-up period. 
Furthermore, groups differed significantly in education. The possible effect on the 
results was statistically controlled for. A natural matching of the groups in terms of 
education was not possible since ARMS individuals showed marked deficits in this 
area.  
 
In conclusion, ARMS-T performed worse than DC in working memory and certain 
executive function tasks. The neurocognitive evaluation of tasks related to these 
domains might in the future be helpful in the differential diagnosis of ARMS 
individuals versus depressive disorders.  
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Figure Legends 
Figure 1 Differences in neurocognitive performance of the groups compared to healthy 
controls. Performance of healthy controls is represented by the baseline.  
Groups: ARMS-T = At Risk Mental State individuals with later transition to psychosis, 
ARMS-NT = At Risk Mental State individuals without later transition, DC = controls 
with depression 
Tests: ToH = Tower of Hanoi; WCST = Wisconsin Card Sorting Test; WM = TAP 
working memory; CPT = Continuous Performance Task  
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Table 1: Criteria for ARMS and transition to psychosis  
 
BPRS = Brief Psychiatric Rating Scale 43; ARMS = at risk mental state for psychosis  
 
 
 
 
  
 
Clinical signs 
 
At Risk 
Mental 
State 
(ARMS) 
A) “Attenuated” psychotic symptoms: psychotic symptoms below the 
transition cut-off (BPRS scales: ratings of hallucinations at 2-3, unusual 
thought content 3-4, or suspiciousness 3-4) at least several times per 
week persisting for >1 week; OR  
B) Brief Limited Intermittent Psychotic Symptoms (BLIPS): psychotic 
symptoms over the transition cut-off (BPRS scales: hallucinations ≥4, 
unusual thought content ≥5, suspiciousness ≥5, conceptual 
disorganization ≥5), but each symptom lasting <1 week before 
resolving spontaneously 
C) Genetic risk category: first or second degree relative with psychotic 
disorder 
        and at least two further risk factors according to the screening 
instrument. 
D) Precondition for all categories: criteria of transition to psychosis remain 
unfulfilled. 
Transition 
to 
Psychosis 
 
A)     At least one of the following symptoms: 
• suspiciousness (BPRS ≥5): subject says others are maliciously talking 
about him/her, have negative intentions or may induce harm (incidents 
more than once a week OR partly delusional conviction). 
• unusual thought content (BPRS ≥5): full delusion(s) with some 
preoccupation OR some areas of functioning disrupted (not only ideas 
of reference/ persecution, unusual beliefs or bizarre ideas without fixed 
delusional conviction) 
• hallucinations (BPRS ≥4): occasional hallucinations OR visual 
illusions >2 week or with functional impairment (not only hearing of 
own name, non-verbal acoustic or formless visual 
hallucinations/illusions). 
• conceptual disorganization (BPRS ≥5): speech difficult to understand 
due to circumstantiality, tangentiality, neologisms, blockings or topic 
shifts (most of the time OR three to five instances of incoherent 
phrases). 
• Symptoms at least several times a week and change in mental state 
lasting for more than one week.  
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Table 2: Socio-demographic and clinical data 
  
  HC DC ARMS-NT ARMS-T Statistics 
N 76 34 27 20   
Gender (m/f) 39/37 14/20 13/14 14/6 
†χ2 = 4.29, df=3,   
p = 0.23  
Age  
(*SD of years) 
24.86  
(±5.71) 
26.24  
(±5.85) 
25.85  
(±8.68) 
26.55  
(±6.96) 
‡χ2 = 2.56, df = 3  
p = 0.46  
Education           
  < 9 years 8 10 4 6   
 9 - 11 years 25 13 11 7 §p < 0.01 
 12 - 13 years 35 3 5 6   
 >14 years 7 7 6 1   
Substance use           
 Neuroleptics  
 (chlorprothixene) 0 0 4 3 
§p = 0.06 
 Antidepressants  0 23 11 7 §p = 0.02 
 Benzodiazepines  0 2 5 1 §p = 0.18 
Cannabis use           
 none 76 28 17 12   
 less than monthly 0 2 5 3   
 monthly 0 1 4 4 §p = 0.40 
 weekly 0 1 0 0   
 daily 0 2 1 1   
 
Groups: HC = healthy control; DC = depressive control; ARMS-NT = At Risk Mental State individuals without later transition to psychosis; ARMS-T = At Risk Mental State individuals 
with later transition to psychosis 
*SD, standard deviation; †Chi-square test; ‡Kruskal-Wallis test; §Monte Carlo test with 2000 replicates  
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Table 3: Depression in DC and ARMS individuals (ICD-10 code) 
 
Diagnosis ICD-10 ARMS-T ARMS-NT DC 
    
Depressive episode (F32) or recurrent 
depressive episode (F33)    
Mild (F32.0/33.0) 1 1 4 
Moderate (F32.1/F33.1)  4 7 17 
Severe (F32.2/F 33.2) - 1 6 
Severe with psychotic symptoms 
(F32.3/F33.3) 2 - - 
Currently in remission (F33.4) - - 1 
    
Depressive episode, not further classified  1 1 4 
    
Dysthymia (F34.1) 1 - - 
    
Adjustment disorder (F43.20, F43.21, F43.22) - 4 2 
    
Total  9/22 14/25 34/34 
Groups: DC = depressive control; ARMS-NT = At Risk Mental State individuals without later transition to 
psychosis; ARMS-T = At Risk Mental State individuals with later transition to psychosis 
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Table 5: Performance of ARMS-T, ARMS-NT, DC versus HC and ARMS-T versus DC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
†MANOVA showed no significance 
‡ANOVA showed no significance 
ToH = Tower of Hanoi; WCST = Wisconsin Card Sorting Test; WM = working memory; CPT = Continous performance task 
 ARMS-T vs HC ARMS-NT vs HC DC vs HC ARMS-T vs DC 
 
Diff in 
Z-
Scores 
95% 
Confidence 
Interval 
p-value 
Diff in 
Z-
Scores 
95% 
Confidence 
Interval 
p-value 
Diff in 
Z-
Scores 
95% 
Confidence 
Interval 
p-value 
Diff in 
Z-
Scores 
95% 
Confidence 
Interval 
p-value 
  
 
lwr upr 
  
lwr upr 
  
lwr upr 
  
lwr upr 
 
Intelligence                
 
nonverbal IQ -0.41 NA†† NA† NA† -0.02 NA† NA† NA† -0.13 NA† NA† NA† -0.28 NA† NA† NA† 
verbal IQ -0.51 NA† NA† NA† -0.52 NA† NA† NA† -0.4 NA† NA† NA† -0.11 NA† NA† NA† 
Executive Function                
 
Tower of Hanoi 4 disc moves -0.74 -1.28 -0.2 <0.01 -0.47 -0.94 0.01 0.06 -0.12 -0.54 0.3 0.87 -0.62 -1.12 -0.02 0.04 
Tower of Hanoi 5 disc moves -0.68 -1.27 -0.09 0.02 -0.34 -0.85 0.18 0.33 -0.08 -0.52 0.37 0.97 -0.6 -1.25 0.05 0.08 
Tower of Hanoi 4 speed -0.39 -1.05 0.27 0.42 -0.19 -0.77 0.39 0.83 -0.69 -1.2 -1.8 <0.01 0.3 -0.43 1.03 0.71 
Tower of Hanoi 5 speed -0.57 -1.24 0.09 0.12 -0.27 -0.86 0.31 0.62 -0.75 -1.25 -0.24 <0.001 0.17 -0.56 0.91 0.93 
WCST perseveration error -0.17 -0.76 0.42 0.88 -0.72 -1.24 -0.19 <0.01 -0.23 -0.7 0.24 0.59 0.06 -0.6 0.72 1.00 
WCST perseveration score -0.32 -0.96 0.33 0.58 -0.63 -1.18 -0.07 0.02 -0.39 -0.9 0.1 0.17 0.08 -0.64 0.79 0.99 
Go/NoGo omission -0.79 -1.32 -0.25 0.001 -0.47 -0.96 0.02 0.06 -0.14 -0.58 0.3 0.84 -0.65 -1.25 -0.05 0.03 
Go/NoGo false alarm -0.64 -1.14 -0.14 <0.01 -0.37 -0.83 0.1 0.17 -0.22 -0.64 0.2 0.52 -0.42 -0.98 0.15 0.22 
Working memory and attention                
 
TAP Working memory omission -1.04 -1.63 -0.44 <0.001 -0.65 -1.2 -0.11 0.01 -0.36 -0.84 0.13 0.24 -0.68 -1.35 -0.01 0.04 
TAP Working memory false alarm -0.97 -1.55 -0.4 <0.001 -0.44 -0.97 0.09 0.14 -0.28 -0.75 0.44 0.41 -0.69 -1.33 -0.05 0.03 
CPT omission -0.44 -1 0.13 0.19 -0.49 -1.02 0.04 0.08 -0.13 -0.6 0.34 0.89 -0.31 -0.95 0.33 0.59 
CPT false alarm -0.53 -1.12 0.06 0.10 -0.69 -1.24 -0.14 <0.01 -0.12 -0.61 0.37 0.93 -0.41 -1.08 0.25 0.37 
CPT slowing 0.13 NA‡ NA‡ NA‡ -0.16 NA‡ NA‡ NA‡ -0.22 NA‡ NA‡ NA‡ 0.35 NA‡ NA‡ NA‡ 
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Groups: HC = healthy control; DC = depressive control; ARMS-NT = At Risk Mental State individuals without later transition to psychosis; ARMS-T = At Risk Mental 
State individuals with later transition to psychosis 
Cognition in ARMS for Psychosis 
  
30
 
Figure1: 
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